Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学FGFR Inhibitor Therapy

Michael Morris

MD

🏢Memorial Sloan Kettering Cancer Center🌐USA

Clinical Director Genitourinary Oncology

90
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Michael Morris leads genitourinary oncology clinical research and has contributed to targeted therapy trials including FGFR inhibitors in urothelial cancer. His work addresses precision oncology in advanced GU malignancies. He has led pivotal prostate cancer trials. He is among the most recognized GU oncologists internationally.

Share:

🧪Research Fields 研究领域

genitourinary cancer
FGFR inhibitors
targeted therapy
clinical trials
prostate cancer

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Michael Morris 的研究动态

Follow Michael Morris's research updates

留下邮箱,当我们发布与 Michael Morris(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment